Circulating levels of Cyclophilin A in women with PCOS : correlation with clinical and biochemical parameters (original) (raw)
A study of inflammatory markers in women with polycystic ovary syndrome
ADITI JAISWAL
2022
View PDFchevron_right
Inflammatory Markers in Women with Polycystic Ovary Syndrome
michał kunicki
BioMed Research International, 2020
View PDFchevron_right
Assessment of plasma level of cyclophilin A in type 2 diabetic patients suffering from vascular diseases
Shereen Farag
Benha Medical Journal, 2018
View PDFchevron_right
Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease
Raman Kutty
Cardiovascular Diabetology, 2014
View PDFchevron_right
Inflammatory and Anti-Inflammatory Parameters in PCOS Patients Depending on Body Mass Index: A Case-Control Study
Polina Popova
Biomedicines
View PDFchevron_right
Chronic inflammation in polycystic ovary syndrome: A case–control study using multiple markers
Dr. Subhadip Choudhuri
2021
View PDFchevron_right
Potential role of cyclophilin A in regulating cytokine secretion
Muhammad Khattak
Journal of leukocyte biology, 2017
View PDFchevron_right
Polycystic ovary syndrome and circulating inflammatory markers
Mohammad Naghizadeh
International journal of reproductive biomedicine (Yazd, Iran), 2017
View PDFchevron_right
Cyclophilin B serum levels present variations across the menstrual cycle
Luis M Botana
Scientific Reports, 2023
View PDFchevron_right
Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-na...
Uneeb Urwat
BMC Women's Health, 2023
View PDFchevron_right
Elevated PAPP-A levels in lean patients with polycystic ovary syndrome
Mesut Oktem
Taiwanese journal of obstetrics & gynecology, 2018
View PDFchevron_right
Low Grade Chronic Inflammation in Women with Polycystic Ovarian Syndrome
Gwyn Gould
The Journal of Clinical Endocrinology & Metabolism, 2001
View PDFchevron_right
Inflammatory and endothelial markers in women with polycystic ovary syndrome
Christina Piperi
European Journal of Clinical Investigation, 2006
View PDFchevron_right
Clinical Significance of Inflammatory Markers in Polycystic Ovary Syndrome: Their Relationship to Insulin Resistance and Body Mass Index
Jalal Hashim
Disease Markers, 2009
View PDFchevron_right
Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study
Mohd Ashraf Ganie
Journal of Pediatric and Adolescent Gynecology, 2017
View PDFchevron_right
Polycystic Ovary Syndrome in Overweight and Normal Weight Women: The Relationships with Inflammatory Markers
Cigdem Yenisey
Bagcilar Medical Bulletin, 2020
View PDFchevron_right
Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome
A. Makedos
Hippokratia, 2011
View PDFchevron_right
Study of Some Cytokines and Hormones in a Sample of Iraqi women with Polycystic ovarian syndrome and Their Relation to Obesity
esam noori
Al Mustansiriyah Journal of Pharmaceutical Sciences
View PDFchevron_right
Association of vascular and inflammatory markers with metabolic disorders in women with polycystic ovary syndrome
Aleksandra Atanasova
Vojnosanitetski pregled, 2019
View PDFchevron_right
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome
Stefano Palomba
2005
View PDFchevron_right
Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case–control study of women from Bahraini medical clinics
Wassim Y Almawi
BMJ Open, 2018
View PDFchevron_right
Role and Usefulness of C-reactive Protein in Women with Polycystic Ovarian Syndrome
Amresh Singh
Journal of Advances in Medicine and Medical Research, 2021
View PDFchevron_right
Cyclophilins modify their profile depending on the organ or tissue in a murine inflammatory model
Nadia Pérez-Fuentes, Luis M Botana
Int Immunopharmacol, 2023
View PDFchevron_right
Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease
Zeev Blumenfeld
The Journal of Clinical Endocrinology & Metabolism, 2004
View PDFchevron_right
Cyclophilin A: a key player for human disease
Patrizia Nigro
Cell Death and Disease, 2013
View PDFchevron_right
Inflammatory markers in lean Polycystic Ovary Syndrome subjects are not associated with the spectrum of dyslipidemia
Andon Hestiantoro
Majalah Obstetri & Ginekologi
View PDFchevron_right
Insulin resistance and its relation to inflammatory status and serum lipids among young women with PCOS
Rupa Vani
International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2013
View PDFchevron_right
Cardiovascular Risk Factors Insulin Resistance [IR], High Sensitivity C-reactive Protein (hs-CRP) and Fibrinogen in Pre- Menopausal women with Poly cystic ovarian syndrome (PCOS)
Purvi Purohit
Journal of Cardiovascular Disease Research, 2015
View PDFchevron_right